326 related articles for article (PubMed ID: 33059819)
1. Imaging for Response Assessment in Cancer Clinical Trials.
Sorace AG; Elkassem AA; Galgano SJ; Lapi SE; Larimer BM; Partridge SC; Quarles CC; Reeves K; Napier TS; Song PN; Yankeelov TE; Woodard S; Smith AD
Semin Nucl Med; 2020 Nov; 50(6):488-504. PubMed ID: 33059819
[TBL] [Abstract][Full Text] [Related]
2. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Wahl RL; Jacene H; Kasamon Y; Lodge MA
J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):122S-50S. PubMed ID: 19403881
[TBL] [Abstract][Full Text] [Related]
5. Functional and molecular imaging in cancer drug development.
Bollineni VR; Collette S; Liu Y
Chin Clin Oncol; 2014 Jun; 3(2):17. PubMed ID: 25841413
[TBL] [Abstract][Full Text] [Related]
6. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ
Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336
[TBL] [Abstract][Full Text] [Related]
7. Measurement Repeatability of
Fraum TJ; Fowler KJ; Crandall JP; Laforest RA; Salter A; An H; Jacobs MA; Grigsby PW; Dehdashti F; Wahl RL
J Nucl Med; 2019 Aug; 60(8):1080-1086. PubMed ID: 30733325
[TBL] [Abstract][Full Text] [Related]
8. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.
Shukla-Dave A; Obuchowski NA; Chenevert TL; Jambawalikar S; Schwartz LH; Malyarenko D; Huang W; Noworolski SM; Young RJ; Shiroishi MS; Kim H; Coolens C; Laue H; Chung C; Rosen M; Boss M; Jackson EF
J Magn Reson Imaging; 2019 Jun; 49(7):e101-e121. PubMed ID: 30451345
[TBL] [Abstract][Full Text] [Related]
9. Comparison of
Ling SW; de Jong AC; Schoots IG; Nasserinejad K; Busstra MB; van der Veldt AAM; Brabander T
Eur Urol Open Sci; 2021 Nov; 33():61-71. PubMed ID: 34632423
[TBL] [Abstract][Full Text] [Related]
10. Semiautomatically Quantified Tumor Volume Using
Seifert R; Herrmann K; Kleesiek J; Schäfers M; Shah V; Xu Z; Chabin G; Grbic S; Spottiswoode B; Rahbar K
J Nucl Med; 2020 Dec; 61(12):1786-1792. PubMed ID: 32332147
[TBL] [Abstract][Full Text] [Related]
11. ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).
Emmett L; Subramaniam S; Joshua AM; Crumbaker M; Martin A; Zhang AY; Rana N; Langford A; Mitchell J; Yip S; Francis R; Hofman MS; Sandhu S; Azad A; Gedye C; McJannett M; Stockler MR; Davis ID;
BJU Int; 2021 Nov; 128(5):642-651. PubMed ID: 34028967
[TBL] [Abstract][Full Text] [Related]
12. Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group.
deSouza NM; Liu Y; Chiti A; Oprea-Lager D; Gebhart G; Van Beers BE; Herrmann K; Lecouvet FE
Eur J Cancer; 2018 Mar; 91():153-163. PubMed ID: 29331524
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
Zimmermann C; Distler M; Jentsch C; Blum S; Folprecht G; Zöphel K; Polster H; Troost EGC; Abolmaali N; Weitz J; Baumann M; Saeger HD; Grützmann R
Strahlenther Onkol; 2021 Jan; 197(1):19-26. PubMed ID: 32638040
[TBL] [Abstract][Full Text] [Related]
15. SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.
Chinnappan S; Chandra P; Kumar JS; Chandran G; Nath S
Indian J Nucl Med; 2021; 36(4):377-384. PubMed ID: 35125755
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric functional MRI and
Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
[TBL] [Abstract][Full Text] [Related]
17. Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.
Theruvath AJ; Siedek F; Muehe AM; Garcia-Diaz J; Kirchner J; Martin O; Link MP; Spunt S; Pribnow A; Rosenberg J; Herrmann K; Gatidis S; Schäfer JF; Moseley M; Umutlu L; Daldrup-Link HE
Radiology; 2020 Jul; 296(1):143-151. PubMed ID: 32368961
[TBL] [Abstract][Full Text] [Related]
18. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
19. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy and the role of imaging.
Carter BW; Bhosale PR; Yang WT
Cancer; 2018 Jul; 124(14):2906-2922. PubMed ID: 29671876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
